Literature DB >> 15494618

Association of hyperhomocysteinemia in Alzheimer disease with elevated neopterin levels.

Katharina Schroecksnadel1, Friedrich Leblhuber, Barbara Frick, Barbara Wirleitner, Dietmar Fuchs.   

Abstract

In patients with dementias including Alzheimer disease (AD), elevated blood concentrations of homocysteine are common, often going along with low normal folate and vitamin B12. Immune activation leading to oxidative stress also seems to play an important role in the pathogenesis of AD. To find out a possible relationship between immune activation and the development of moderate hyperhomocysteinemia, we determined serum concentrations of homocysteine, folate, vitamin B12 and immune activation markers 75 kD soluble TNF receptor (sTNF-R75) and neopterin in 38 patients with clinically diagnosed AD. A subgroup of patients (45%) presented with increased homocysteine concentrations in comparison to reference ranges in healthy controls of similar age. Also, concentrations of immune activation markers were elevated in a significant proportion of patients. In 17 patients with moderate hyperhomocysteinemia, concentrations of neopterin were higher than in those with lower homocysteine (p < 0.001). Homocysteine correlated with folate (rs= -0.43; p < 0.01) and neopterin (rs= 0.506; p < 0.001). The data suggest that immune activation and concomitant production of reactive oxygen species in patients with AD could be involved in the development of hyperhomocysteinemia via an enhanced decomposition of folate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494618     DOI: 10.1097/01.wad.0000127443.23312.31

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  6 in total

1.  Polyneuropathy and dementia in old age: common inflammatory and vascular parameters.

Authors:  Friedrich Leblhuber; Katharina Schroecksnadel; Margit Beran-Praher; Herbert Haller; Kostja Steiner; Dietmar Fuchs
Journal:  J Neural Transm (Vienna)       Date:  2011-02-01       Impact factor: 3.575

Review 2.  Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Authors:  Jia-Min Zhuo; Hong Wang; Domenico Praticò
Journal:  Trends Pharmacol Sci       Date:  2011-06-20       Impact factor: 14.819

3.  Early increase of plasma homocysteine in sepsis patients with poor outcome.

Authors:  Martin Ploder; Katharina Kurz; Andreas Spittler; Gabriele Neurauter; Erich Roth; Dietmar Fuchs
Journal:  Mol Med       Date:  2010-03-26       Impact factor: 6.354

4.  Homocysteine but not neopterin declines in demented patients on B vitamins.

Authors:  B Frick; B Gruber; K Schroecksnadel; F Leblhuber; D Fuchs
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

5.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 6.  The Immunopathogenesis of Alzheimer's Disease Is Related to the Composition of Gut Microbiota.

Authors:  Friedrich Leblhuber; Daniela Ehrlich; Kostja Steiner; Simon Geisler; Dietmar Fuchs; Lukas Lanser; Katharina Kurz
Journal:  Nutrients       Date:  2021-01-25       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.